Screener
Bristol-Myers Squibb BMY Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Based on trailing twelve months.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's return on invested capital?
- Bristol-Myers Squibb (BMY) reported return on invested capital of 16.7% in Q2 2026.
- How has Bristol-Myers Squibb's return on invested capital changed year-over-year?
- Bristol-Myers Squibb's return on invested capital increased by 100.5% year-over-year, from 8.3% to 16.7%.
- What is the long-term trend for Bristol-Myers Squibb's return on invested capital?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's return on invested capital has grown at a 8.0% compound annual growth rate (CAGR), from -8.5% to 12.5%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Bristol-Myers Squibb's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude